Efficacy and safety of baricitinib or ravulizumab in adult patients with severe COVID-19 (TACTIC-R): a randomised, parallel-arm, open-label, phase 4 trial

TACTIC-R Investigators Group, Frances C. Hall*, Joseph Cheriyan, Andrew P. Cope, James Galloway, Ian Wilkinson, Simon Bond, Sam Norton, Edward Banham-Hall, Hannah Bayes, Michalis Kostapanos, Marianna Nodale, William G. Petchey, Thomas Sheeran, Jonathan Underwood, David R. Jayne, William Petchey, Deepak Nagra, Georgina Bird, Rhys John DaviesDonall Forde, Clemency Nye, Andrea Balan, Sam Bird, Vianne Britten, Lauren Broad, Teriann Evans, Sharon Frayling, Laura Gray, Matthew Haynes, Catherine Oliver, Karen Rahilly, Gail Williams, Tanwir Ahmed, Carrie Bayliss, Natalie Byrne, Elena Hernan-Sancho, Mary Kasanicki, Louise Stockley, Heike Templin, Marie Fisk, James Goodman, Johann Graggaber, Joanna Gray, Peta Masters, Neil S. Sheerin, Andrew P. Cope, Louise Pollard, Joanna Willis, Jennifer Vidler, Jan Flaherty, Georgios K Dimitriadis

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

10 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Efficacy and safety of baricitinib or ravulizumab in adult patients with severe COVID-19 (TACTIC-R): a randomised, parallel-arm, open-label, phase 4 trial'. Together they form a unique fingerprint.

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science